Introduction: Central retinal vein occlusion (CRVO) is clinically classified into ischemic and non-ischemic varieties. Non-ischemic CRVO presents with the blurring of vision and posterior segment findings such as hemorrhages, tortuous blood vessels, cotton-wool spots, and macular edema. Sometimes, cystoid macular edema may be present. Patient Information: A 30-year-old man was diagnosed with non-ischemic CRVO and cystoid macular edema in his right eye. The patient had taken multiple rounds of intraocular injection. The visual acuity of the patient was LogMAR 0.602 in his right eye and LogMAR 0 in his left eye. Posterior segment examination of the patient showed cotton-wool spots, tortuous blood vessels, and some hemorrhages. Optical coherence tomography showed multiple cyst-like lesions at the macula. The patient was treated with four courses of inpatient therapy comprising Ayurveda oral medicines (Kvatha, Churna, and Gutika), Kriyakalpa (local ophthalmic therapies such as Seka, Ashchyotana, Pindi, and Bidalaka), and treatments for the head such as Siroveshtana and Lepa. After treatment the visual acuity readings of the patient was improved, and most of the posterior segment findings were found resolved. Conclusion: The patient experienced positive changes from the treatment. Ayurvedamanagement can be a therapeutic option for non-ischemic CRVO and cystoid macular edema.
{"title":"Management of non-ischemic central retinal vein occlusion with cystoid maular edema through Ayurveda interventions: A case report","authors":"Vidya Sugunan, Narayanan Namboothiri Narayanan, Aravind Kumar, K. Sukumaran, Kavya Varma","doi":"10.4103/jras.jras_25_21","DOIUrl":"https://doi.org/10.4103/jras.jras_25_21","url":null,"abstract":"Introduction: Central retinal vein occlusion (CRVO) is clinically classified into ischemic and non-ischemic varieties. Non-ischemic CRVO presents with the blurring of vision and posterior segment findings such as hemorrhages, tortuous blood vessels, cotton-wool spots, and macular edema. Sometimes, cystoid macular edema may be present. Patient Information: A 30-year-old man was diagnosed with non-ischemic CRVO and cystoid macular edema in his right eye. The patient had taken multiple rounds of intraocular injection. The visual acuity of the patient was LogMAR 0.602 in his right eye and LogMAR 0 in his left eye. Posterior segment examination of the patient showed cotton-wool spots, tortuous blood vessels, and some hemorrhages. Optical coherence tomography showed multiple cyst-like lesions at the macula. The patient was treated with four courses of inpatient therapy comprising Ayurveda oral medicines (Kvatha, Churna, and Gutika), Kriyakalpa (local ophthalmic therapies such as Seka, Ashchyotana, Pindi, and Bidalaka), and treatments for the head such as Siroveshtana and Lepa. After treatment the visual acuity readings of the patient was improved, and most of the posterior segment findings were found resolved. Conclusion: The patient experienced positive changes from the treatment. Ayurvedamanagement can be a therapeutic option for non-ischemic CRVO and cystoid macular edema.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130507492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This case report presents the treatment outcome of a 9-year-old diagnosed case of acute recurrent pancreatitis (ARP). The patient has suffered recurrent severe abdominal pain, vomiting, and constipation for the past 3 years. The high amylase and lipase levels in the serum, ultrasonography, and magnetic resonance cholangiopancreatography findings confirmed the diagnosis of ARP. The patient regularly took allopathic medicines, yet she had recurrent abdominal pain episodes that required hospitalization. The patient was treated with Ayurveda medicines, including Kamadudha Rasa (Mukta Yukta), Agnitundi Vati (twice daily before meals), and Nityam tablet at bedtime for 3 weeks. In the third week, the treatment was modified by replacing Agnitundi Vati with Kravyad Rasa and Kankayana Vati. The 8-month continued therapy resulted in complete clinical recovery. No adverse reactions or untoward effects due to Ayurveda interventions were reported during the treatment. There was no recurrence after a 90-day follow-up. Based on the results obtained in this case study, a clinical trial on Ayurvedic management of ARP may be planned to prove the efficacy of Ayurveda treatment regimen in treating ARP empirically.
本病例报告提出了一个9岁的诊断病例急性复发性胰腺炎(ARP)的治疗结果。3年来，患者反复出现严重腹痛、呕吐和便秘。血清淀粉酶和脂肪酶水平高，超声和磁共振胰胆管造影结果证实了ARP的诊断。患者定期服用对症药物，但仍有反复腹痛，需要住院治疗。患者给予阿育吠陀药物治疗，包括Kamadudha Rasa (Mukta Yukta)、Agnitundi Vati(每日两次饭前)和Nityam片睡前治疗，持续3周。第三周，将Agnitundi Vati改为Kravyad Rasa和Kankayana Vati。8个月的持续治疗使患者临床完全康复。在治疗期间，没有报告由于阿育吠陀干预而产生的不良反应或不良反应。90天随访无复发。基于本病例研究结果，拟开展阿育吠陀治疗ARP的临床试验，从经验上证明阿育吠陀治疗方案治疗ARP的有效性。
{"title":"Effect of Ayurvedic medicines in the management of acute recurrent pancreatitis: A case report","authors":"M. Padhi, H. Panigrahi, G. Lavekar","doi":"10.4103/jras.jras_7_22","DOIUrl":"https://doi.org/10.4103/jras.jras_7_22","url":null,"abstract":"This case report presents the treatment outcome of a 9-year-old diagnosed case of acute recurrent pancreatitis (ARP). The patient has suffered recurrent severe abdominal pain, vomiting, and constipation for the past 3 years. The high amylase and lipase levels in the serum, ultrasonography, and magnetic resonance cholangiopancreatography findings confirmed the diagnosis of ARP. The patient regularly took allopathic medicines, yet she had recurrent abdominal pain episodes that required hospitalization. The patient was treated with Ayurveda medicines, including Kamadudha Rasa (Mukta Yukta), Agnitundi Vati (twice daily before meals), and Nityam tablet at bedtime for 3 weeks. In the third week, the treatment was modified by replacing Agnitundi Vati with Kravyad Rasa and Kankayana Vati. The 8-month continued therapy resulted in complete clinical recovery. No adverse reactions or untoward effects due to Ayurveda interventions were reported during the treatment. There was no recurrence after a 90-day follow-up. Based on the results obtained in this case study, a clinical trial on Ayurvedic management of ARP may be planned to prove the efficacy of Ayurveda treatment regimen in treating ARP empirically.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"12 12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124380413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.4103/jras.jras_104_21
S. Parameswaran, A. Kumar, K. Sukumaran, Kavya Varma
BACKGROUND: Tolosa-Hunt syndrome (THS) is a rare disorder characterized by episodic periorbital pain associated with paralysis of either one or more of the III, IV, or VI cranial nerves. It is usually self-resolving, but relapse may be seen. In Ayurveda, a clinical condition “Vatahata Vartma” is narrated, resembling THS. Based on the resemblance, a diagnosed case of THS was treated by Ayurveda measures and treatment described for the management of Vatahata Vartma.MATERIALS AND METHODS: A 50-year-old man, who was previously diagnosed and underwent treatment for THS, presented with complaints of increased drooping and swelling at his left upper eyelid along with strenuous eyeball movements since February 2021. Drooping of the eyelids was measured by the amount of ptosis, margin-reflex distance, and the function of the levator palpebrae superioris. The patient was treated with Ayurveda oral medicines (herbal decoctions, herbal clarified butter, herbal powders, and herbal tablets), biopurification (therapeutic purgation and retention of medicine in the buccal cavity), and external Ayurveda ocular therapy (ocular irrigation, bolus sudation, eye drops, herbal paste over the eyelids, retention of herbal clarified butter over the eyes, collyrium, paste over the head, and irrigation over the head). The total duration of therapy was 11 months. RESULTS: Swelling and ptosis of the left upper eyelid were reduced, and the patient could do the normal movement of the left upper eyelid. CONCLUSION: THS can be treated with Ayurveda measures and interventions narrated in Ayurveda under Vatahata Vartma. A clinical study on large sample size is required to validate the result obtained in the present case study.
{"title":"Management of Tolosa-Hunt syndrome with Ayurveda therapeutic measures and interventions: A case report","authors":"S. Parameswaran, A. Kumar, K. Sukumaran, Kavya Varma","doi":"10.4103/jras.jras_104_21","DOIUrl":"https://doi.org/10.4103/jras.jras_104_21","url":null,"abstract":"BACKGROUND: Tolosa-Hunt syndrome (THS) is a rare disorder characterized by episodic periorbital pain associated with paralysis of either one or more of the III, IV, or VI cranial nerves. It is usually self-resolving, but relapse may be seen. In Ayurveda, a clinical condition “Vatahata Vartma” is narrated, resembling THS. Based on the resemblance, a diagnosed case of THS was treated by Ayurveda measures and treatment described for the management of Vatahata Vartma.MATERIALS AND METHODS: A 50-year-old man, who was previously diagnosed and underwent treatment for THS, presented with complaints of increased drooping and swelling at his left upper eyelid along with strenuous eyeball movements since February 2021. Drooping of the eyelids was measured by the amount of ptosis, margin-reflex distance, and the function of the levator palpebrae superioris. The patient was treated with Ayurveda oral medicines (herbal decoctions, herbal clarified butter, herbal powders, and herbal tablets), biopurification (therapeutic purgation and retention of medicine in the buccal cavity), and external Ayurveda ocular therapy (ocular irrigation, bolus sudation, eye drops, herbal paste over the eyelids, retention of herbal clarified butter over the eyes, collyrium, paste over the head, and irrigation over the head). The total duration of therapy was 11 months. RESULTS: Swelling and ptosis of the left upper eyelid were reduced, and the patient could do the normal movement of the left upper eyelid. CONCLUSION: THS can be treated with Ayurveda measures and interventions narrated in Ayurveda under Vatahata Vartma. A clinical study on large sample size is required to validate the result obtained in the present case study.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126568746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Manoj K. Shamkuwar, Shivshankar Rajput, B. Yadav, Sujata Ranjan, Nitin Jindal, L. Sharma, Rakesh Rana, R. Singhal, S. Khanduri, B. Sharma, B. Rao, Narayanam Srikanth, . Bharti, K. Dhiman, R. Manchanda
BACKGROUND: Coronavirus disease (COVID-19) pandemic has evolved as a unique, unprecedented global health crisis that has severely affected the economies and daily lives of people. AYUSH 64 is an Ayurveda formulation repurposed in the COVID-19 management because of its proven efficacy in influenza-like illness. MATERIALS AND METHODS: This was a prospective, open-label, single-arm, pilot study conducted at Ayurveda and Unani Tibbia College (A&U Tibbia) and Hospital, designated COVID-19 health center under the Government of National Capital Territory (NCT) of Delhi. The study population included 40 asymptomatic to mild COVID-19 cases of either sex aged above 18 years admitted to the hospital with positive nasopharyngeal swab test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (reverse-transcription polymerase chain reaction [RT-PCR]) or rapid antigen test. AYUSH 64 tablets in the dose of two tablets (500 mg each) thrice a day after food with warm water were given to the participants for the period of 7–14 days, and once the patient got RT-PCR negative, the medicine was discontinued. RESULTS: Out of 36 completed cases, 28 participants were symptomatic, 39.28% of participants clinically recovered in 7 days of AYUSH 64 intervention, and 53.5% of participants clinically recovered in 14 days. The mean time for clinical recovery was 7.04 days (±2.88 days standard deviation). No adverse drug reaction was found in any of the participants. Serious adverse event unrelated to the trial drug was reported in two participants (5%) within 24 h of enrolment. CONCLUSION: Among asymptomatic and mild COVID-19 cases, the repurposing of AYUSH 64 was found effective and quite safe to alleviate infection with a significant clinical recovery within 14 days. Subsequent research on a larger scale is warranted for statistically robust evidences in the treatment of COVID-19.
{"title":"Ayurveda formulation AYUSH 64 in asymptomatic and mild COVID-19 infection—A single-arm, open-label, prospective, pilot study","authors":"Manoj K. Shamkuwar, Shivshankar Rajput, B. Yadav, Sujata Ranjan, Nitin Jindal, L. Sharma, Rakesh Rana, R. Singhal, S. Khanduri, B. Sharma, B. Rao, Narayanam Srikanth, . Bharti, K. Dhiman, R. Manchanda","doi":"10.4103/jras.jras_97_22","DOIUrl":"https://doi.org/10.4103/jras.jras_97_22","url":null,"abstract":"BACKGROUND: Coronavirus disease (COVID-19) pandemic has evolved as a unique, unprecedented global health crisis that has severely affected the economies and daily lives of people. AYUSH 64 is an Ayurveda formulation repurposed in the COVID-19 management because of its proven efficacy in influenza-like illness. MATERIALS AND METHODS: This was a prospective, open-label, single-arm, pilot study conducted at Ayurveda and Unani Tibbia College (A&U Tibbia) and Hospital, designated COVID-19 health center under the Government of National Capital Territory (NCT) of Delhi. The study population included 40 asymptomatic to mild COVID-19 cases of either sex aged above 18 years admitted to the hospital with positive nasopharyngeal swab test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (reverse-transcription polymerase chain reaction [RT-PCR]) or rapid antigen test. AYUSH 64 tablets in the dose of two tablets (500 mg each) thrice a day after food with warm water were given to the participants for the period of 7–14 days, and once the patient got RT-PCR negative, the medicine was discontinued. RESULTS: Out of 36 completed cases, 28 participants were symptomatic, 39.28% of participants clinically recovered in 7 days of AYUSH 64 intervention, and 53.5% of participants clinically recovered in 14 days. The mean time for clinical recovery was 7.04 days (±2.88 days standard deviation). No adverse drug reaction was found in any of the participants. Serious adverse event unrelated to the trial drug was reported in two participants (5%) within 24 h of enrolment. CONCLUSION: Among asymptomatic and mild COVID-19 cases, the repurposing of AYUSH 64 was found effective and quite safe to alleviate infection with a significant clinical recovery within 14 days. Subsequent research on a larger scale is warranted for statistically robust evidences in the treatment of COVID-19.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115753811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.4103/jras.jras_133_22
Rabina Acharya
{"title":"Ayurveda therapeutic and preventive approach: Need for research to create a potential strategy for noncommunicable diseases","authors":"Rabina Acharya","doi":"10.4103/jras.jras_133_22","DOIUrl":"https://doi.org/10.4103/jras.jras_133_22","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131063368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.4103/jras.jras_100_22
Rabina Acharya
{"title":"Multidisciplinary approach for clinical diagnosis in traditional medicine: Towards personalized and targeted therapies","authors":"Rabina Acharya","doi":"10.4103/jras.jras_100_22","DOIUrl":"https://doi.org/10.4103/jras.jras_100_22","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129289740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pallavi S. Mundada, D. Makhija, Mata Sunita, B. Rao, Arunabh Tripathi, Kalpana Kachre, R. Singhal, Rakesh Rana, Adarsh Kumar, Narayanam Srikanth
BACKGROUND: The rise in the number of newly reported cases heralds the onset of the third wave of COVID-19 in India, despite the country’s relentless push for COVID-19 vaccination. In such a situation, efforts other than the vaccination, to strengthen the population’s immune system have become critical to keep the overburdened health-care system from being exhausted. Ayuraksha Kit includes four Ayurveda medicines viz., Chyawanprash, Samshamani Vati, Anu Taila and Ayush Kwath choorna. This kit is developed with an aim to enhance the general wellbeing and immunity of apparently healthy individuals. During the COVID-19 pandemic, this trial will investigate the impact of the Ayuraksha Kit as an adjunct to standard preventative measures in safeguarding people living in 12 Indian cities. MATERIALS AND METHODS: A community-based cluster randomized controlled trial will be conducted on 8316 apparently healthy adults. The clusters will be randomly allocated to two groups, intervention and control groups, in a 10:1 ratio. The advice on standard preventive measures along with masks and soaps for hand hygiene will be provided to all the study participants in both groups. Ayuraksha Kit will be given for one month to the 7560 study participants in the intervention group, and the 756 participants in the control group will be only given standard preventive measures. Effect of Ayuraksha Kit on incidence and severity of COVID-19 like symptoms and the psychological distress as an impact of risk of exposure to SARS CoV-2 will be assessed during this study. DISCUSSION AND CONCLUSION: As this study will be conducted in the areas predominantly resided by people belonging to scheduled castes in Indian cities, this cluster-RCT will determine whether the use of Ayuraksha Kit has a prophylactic potential against the incidence or on the severity of disease. TRIAL REGISTRATION: CTRI/2022/02/040156 dated 10th February 2022.
{"title":"A prophylactic community-based study to assess the impact of Ayuraksha kit in COVID-19: A study Protocol of a cluster randomised trial","authors":"Pallavi S. Mundada, D. Makhija, Mata Sunita, B. Rao, Arunabh Tripathi, Kalpana Kachre, R. Singhal, Rakesh Rana, Adarsh Kumar, Narayanam Srikanth","doi":"10.4103/jras.jras_49_22","DOIUrl":"https://doi.org/10.4103/jras.jras_49_22","url":null,"abstract":"BACKGROUND: The rise in the number of newly reported cases heralds the onset of the third wave of COVID-19 in India, despite the country’s relentless push for COVID-19 vaccination. In such a situation, efforts other than the vaccination, to strengthen the population’s immune system have become critical to keep the overburdened health-care system from being exhausted. Ayuraksha Kit includes four Ayurveda medicines viz., Chyawanprash, Samshamani Vati, Anu Taila and Ayush Kwath choorna. This kit is developed with an aim to enhance the general wellbeing and immunity of apparently healthy individuals. During the COVID-19 pandemic, this trial will investigate the impact of the Ayuraksha Kit as an adjunct to standard preventative measures in safeguarding people living in 12 Indian cities. MATERIALS AND METHODS: A community-based cluster randomized controlled trial will be conducted on 8316 apparently healthy adults. The clusters will be randomly allocated to two groups, intervention and control groups, in a 10:1 ratio. The advice on standard preventive measures along with masks and soaps for hand hygiene will be provided to all the study participants in both groups. Ayuraksha Kit will be given for one month to the 7560 study participants in the intervention group, and the 756 participants in the control group will be only given standard preventive measures. Effect of Ayuraksha Kit on incidence and severity of COVID-19 like symptoms and the psychological distress as an impact of risk of exposure to SARS CoV-2 will be assessed during this study. DISCUSSION AND CONCLUSION: As this study will be conducted in the areas predominantly resided by people belonging to scheduled castes in Indian cities, this cluster-RCT will determine whether the use of Ayuraksha Kit has a prophylactic potential against the incidence or on the severity of disease. TRIAL REGISTRATION: CTRI/2022/02/040156 dated 10th February 2022.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"263 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132814425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BACKGROUND: The spine of Vallibadara [Ziziphus oenoplia (L.) Mill.] of family Rhamnaceae are traditionally claimed to manage Mukhadushika (acne vulgaris). In Ayurveda, Avipattikara Churna is known for its Pitta Shamka and mild laxative action. The vitiation of Pitta Dosha and constipation are also contribute to manifestation of acne. PATIENT INFORMATION AND INTERVENTION: A 19 year old patient presented with complaints of papules and pustules, scattered all over her forehead and cheeks since last one year. The patient also reported constipation and heartburn since many months. She was diagnosed with Mukhadushika and was treated with the local application of the paste of powdered thorn of Z. oenoplia mixed with lemon juice and oral administration of Avipattikara Churna 4 gm twice daily with water for 21 days. RESULT: Considerable reduction was observed in the scattered papules and pustules on the forehead and cheeks of the patient. Constipation and burning sensation in the chest were relieved after one week. Complete relief in symptoms was noticed after 21 days of treatment. No recurrence of eruptions was observed during the follow-up after 30 days. CONCLUSION: The external application of spine of Z. oenoplia and internal administration of Avipattikara Churna are effective in the treatment of acne vulgaris.
{"title":"Effect of Ayurveda interventions Vallibadara [Ziziphus oenoplia (L.) Mill.] and Avipattikara Churna in the management of Mukhadushika (acne) - a case report","authors":"Payal H. Purohit, R. Acharya","doi":"10.4103/jras.jras_29_22","DOIUrl":"https://doi.org/10.4103/jras.jras_29_22","url":null,"abstract":"BACKGROUND: The spine of Vallibadara [Ziziphus oenoplia (L.) Mill.] of family Rhamnaceae are traditionally claimed to manage Mukhadushika (acne vulgaris). In Ayurveda, Avipattikara Churna is known for its Pitta Shamka and mild laxative action. The vitiation of Pitta Dosha and constipation are also contribute to manifestation of acne. PATIENT INFORMATION AND INTERVENTION: A 19 year old patient presented with complaints of papules and pustules, scattered all over her forehead and cheeks since last one year. The patient also reported constipation and heartburn since many months. She was diagnosed with Mukhadushika and was treated with the local application of the paste of powdered thorn of Z. oenoplia mixed with lemon juice and oral administration of Avipattikara Churna 4 gm twice daily with water for 21 days. RESULT: Considerable reduction was observed in the scattered papules and pustules on the forehead and cheeks of the patient. Constipation and burning sensation in the chest were relieved after one week. Complete relief in symptoms was noticed after 21 days of treatment. No recurrence of eruptions was observed during the follow-up after 30 days. CONCLUSION: The external application of spine of Z. oenoplia and internal administration of Avipattikara Churna are effective in the treatment of acne vulgaris.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"179 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133670895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A 34-year-old female patient presented with a prolonged history of absence of menstruation and dyspareunia was clinically diagnosed as Artava Kshaya (amenorrhea). She was treated with Vamana Purva Snehapana (oral ingestion of fats) with Guggulutikta Ghrita and Aragvadha Mahatikta Ghrita followed by Vamana (emesis therapy) and Mahakalyanaka Ghrita Snehapana followed by Virechana (purgation therapy). On the 15th day after Shodhana and Samsarjana Karma (dietetic regimen after therapeutic purgation), the menstrual cycle appeared after ten years. The patient weight was reduced by 5 kg after the completion of therapeutic emesis and purgation. Symptomatic improvement was observed in concurrent symptoms such as dyspareunia and puffiness of the face. The patient was observed for the next two years without any therapeutic intervention, and she had regular menstrual cycles with moderate flow during that period. This case demonstrates the role of Vamana and Virechana in the management of Artava Kshaya.
{"title":"Management of secondary amenorrhea and PCOS by Vamana and Virechana - a case report","authors":"T. Prarthana, V. Rao","doi":"10.4103/jras.jras_37_21","DOIUrl":"https://doi.org/10.4103/jras.jras_37_21","url":null,"abstract":"A 34-year-old female patient presented with a prolonged history of absence of menstruation and dyspareunia was clinically diagnosed as Artava Kshaya (amenorrhea). She was treated with Vamana Purva Snehapana (oral ingestion of fats) with Guggulutikta Ghrita and Aragvadha Mahatikta Ghrita followed by Vamana (emesis therapy) and Mahakalyanaka Ghrita Snehapana followed by Virechana (purgation therapy). On the 15th day after Shodhana and Samsarjana Karma (dietetic regimen after therapeutic purgation), the menstrual cycle appeared after ten years. The patient weight was reduced by 5 kg after the completion of therapeutic emesis and purgation. Symptomatic improvement was observed in concurrent symptoms such as dyspareunia and puffiness of the face. The patient was observed for the next two years without any therapeutic intervention, and she had regular menstrual cycles with moderate flow during that period. This case demonstrates the role of Vamana and Virechana in the management of Artava Kshaya.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134585744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vinod K Lavaniya, Madan Sharma, S. Thrigulla, V. Rakesh Narayanan, M. Chincholikar, V. Ashwathykutty, Adarsh Kumar, Narayanam Srikanth
Ayurvedagranthasamuccayah is a web portal developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) wherein all the major classical compendiums of Ayurveda are made available on a web-based platform to enable students, practitioners, academicians, and researchers of Ayurveda to have readily accessible and searchable information. The key features of the portal include easy navigation of books with the help of list-based dropdowns and arrow buttons, various scripts to suit the reading purpose of the reader, search facility for any particular term in all the books simultaneously, and results in Key Word in Context format, search function up to five terms simultaneously, and edutainment tools such as Shalaka pariksha and “Random Sutra” for testing and improving one’s knowledge. To increase awareness of the Āyurvedagranthasamuccayah, this short communication outlines the capabilities and utility of the web-based platform.
{"title":"Ayurvedagranthasamuccayah: A digital library of multilingual searchable electronic books of Ayurveda","authors":"Vinod K Lavaniya, Madan Sharma, S. Thrigulla, V. Rakesh Narayanan, M. Chincholikar, V. Ashwathykutty, Adarsh Kumar, Narayanam Srikanth","doi":"10.4103/jras.jras_36_22","DOIUrl":"https://doi.org/10.4103/jras.jras_36_22","url":null,"abstract":"Ayurvedagranthasamuccayah is a web portal developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) wherein all the major classical compendiums of Ayurveda are made available on a web-based platform to enable students, practitioners, academicians, and researchers of Ayurveda to have readily accessible and searchable information. The key features of the portal include easy navigation of books with the help of list-based dropdowns and arrow buttons, various scripts to suit the reading purpose of the reader, search facility for any particular term in all the books simultaneously, and results in Key Word in Context format, search function up to five terms simultaneously, and edutainment tools such as Shalaka pariksha and “Random Sutra” for testing and improving one’s knowledge. To increase awareness of the Āyurvedagranthasamuccayah, this short communication outlines the capabilities and utility of the web-based platform.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123053376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：